JENNIFER HALL: Open Payments
NPI 1528473824 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 12 payments from 7 companies in 2025. Trend: 2023 $243 · 2024 $576 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 1 | $185 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lilly USA, LLC | 2 | $58 |
| ABBVIE INC. | 3 | $57 |
| Abbott Laboratories | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: FILMARRAY, VRAYLAR, FARXIGA, JARDIANCE, MOUNJARO, JOT DX, BREZTRI, LEQVIO.
Industry payments across SC — which companies pay providers there.
